methylprednisolone acetate 40 MG/ML Injectable Suspension
- RxCUI
- 1358610
- RxNorm name
- methylprednisolone acetate 40 MG/ML Injectable Suspension
- Display name
- methylPREDNISolone (Injectable)
- Full name
- methylprednisolone acetate 40 MG/ML Injectable Suspension
- Term type
- SCD
- Status
- Active
- Strength
- 40 mg/ml
- Dose form
- Susp
- Route
- Injectable
- Updated
- 2026-07-24 06:52:10
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 122012
- Active start
- 122012
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| methylprednisolone acetate | 40 MG / 1 ML | methylprednisolone | methylprednisolone acetate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injectable Suspension | 316950 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| methylprednisolone | 6902 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | NAMES |
| RxNorm Name | methylprednisolone acetate 40 MG/ML Injectable Suspension | NAMES |
| TTY | SCD | ATTRIBUTES |
| SPL_SET_ID | 631f7d3e-5620-4be3-b918-2f0d38a97890 | CODES |
| SPL_SET_ID | 904b098c-9068-42ed-958f-6ab78ea42b1f | CODES |
| SPL_SET_ID | a0cbcdb5-f657-49f7-8f86-cc5959d69db0 | CODES |
| SPL_SET_ID | a363f0cd-9c8e-4622-9271-171706846b96 | CODES |
| SPL_SET_ID | de12f38c-ffa1-4d62-b9cb-238a263f6fea | CODES |
| SPL_SET_ID | dec92845-e713-42a3-83a7-3a48920b7eed | CODES |
| SPL_SET_ID | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | CODES |
| SPL_SET_ID | f98314ea-a4e4-4f78-987b-3e9b45a08bb4 | CODES |
| RxCUI | 1358610 | CODES |
| MMSL_CODE | CD2312 | CODES |
| MMSL_CODE | MTH_RXN_BD2312 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0781-3522-70 | 0781-3522 | METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE ACETATE | Sandoz Inc. | ANDA214870 |
| 0781-3522-75 | 0781-3522 | METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE ACETATE | Sandoz Inc. | ANDA214870 |
| 25021-820-05 | 25021-820 | methylprednisolone acetate methylprednisolone acetate | Sagent Pharmaceuticals | ANDA201835 |
| 25021-820-10 | 25021-820 | methylprednisolone acetate methylprednisolone acetate | Sagent Pharmaceuticals | ANDA201835 |
| 42023-238-01 | 42023-238 | METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE ACETATE | Endo USA, Inc. | ANDA214297 |
| 42023-239-01 | 42023-239 | METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE ACETATE | Endo USA, Inc. | ANDA214297 |
| 55150-313-01 | 55150-313 | Methylprednisolone Acetate Methylprednisolone Acetate | Eugia US LLC | ANDA211930 |
| 55150-313-25 | 55150-313 | Methylprednisolone Acetate Methylprednisolone Acetate | Eugia US LLC | ANDA211930 |
| 70121-1609-1 | 70121-1609 | Methylprednisolone acetate Methylprednisolone acetate | Amneal Pharmaceuticals LLC | ANDA216502 |
| 70121-1609-5 | 70121-1609 | Methylprednisolone acetate Methylprednisolone acetate | Amneal Pharmaceuticals LLC | ANDA216502 |
| 85766-195-05 | 85766-195 | methylprednisolone acetate methylprednisolone acetate | Sportpharm LLC | ANDA201835 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA214870 | 0781-3522 | METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE ACETATE | ANDA | Sandoz Inc. |
| ANDA201835 | 25021-820 | methylprednisolone acetate methylprednisolone acetate | ANDA | Sagent Pharmaceuticals |
| ANDA214297 | 42023-238 | METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE ACETATE | ANDA | Endo USA, Inc. |
| ANDA211930 | 55150-313 | Methylprednisolone Acetate Methylprednisolone Acetate | ANDA | Eugia US LLC |
| ANDA216502 | 70121-1609 | Methylprednisolone acetate Methylprednisolone acetate | ANDA | Amneal Pharmaceuticals LLC |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylprednisolone Acetate | METHYLPREDNISOLONE ACETATE | Eugia US LLC | a0cbcdb5-f657-49f7-8f86-cc5959d69db0 | 2026-04-21 | Warnings, Adverse reactions | 55150-313-01 55150-313-25 55150-313 55150031301 55150031325 1358610 |
| methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Sportpharm LLC | 904b098c-9068-42ed-958f-6ab78ea42b1f | 2026-04-01 | Warnings, Adverse reactions | 85766-195-05 85766-195 85766019505 1358610 |
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Pharmacia & Upjohn Company LLC | 823b0010-2b57-4e76-b5ac-4a8c2963438f | 2026-01-21 | Warnings, Adverse reactions | 00009028051 00009028052 00009028003 00009028002 1358610 |
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Pharmacia & Upjohn Company LLC | 9a7b3837-e038-48bf-97e9-78ad463760dc | 2026-01-21 | Warnings, Adverse reactions | 00009307303 00009307301 |
| Methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Amneal Pharmaceuticals LLC | de12f38c-ffa1-4d62-b9cb-238a263f6fea | 2025-12-31 | Warnings, Adverse reactions | 70121-1609-1 70121-1609-5 70121-1609 70121160901 70121160905 1358610 |
| methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Sagent Pharmaceuticals | f98314ea-a4e4-4f78-987b-3e9b45a08bb4 | 2025-03-02 | Warnings, Adverse reactions | 25021-820-10 25021-820-05 25021-820 25021082010 25021082005 1358610 |
| Physicians EZ Use M-pred | METHYLPREDNISOLONE ACETATE, BUPIVACAINE HYDROCHLORIDE, POVIDONE-IODINE | Asclemed USA, Inc. | dec92845-e713-42a3-83a7-3a48920b7eed | 2024-10-30 | Boxed warning, Warnings, Adverse reactions | 0781-3522-75 00781352275 1358610 |
| DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | A-S Medication Solutions | aa151d12-bd33-4d26-848f-2195172c9700 | 2024-06-03 | Warnings, Adverse reactions | 1358610 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 823b0010-2b57-4e76-b5ac-4a8c2963438f | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | 22 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | 20260121 |
| 823b0010-2b57-4e76-b5ac-4a8c2963438f | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | 22 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | 20260121 |
| 631f7d3e-5620-4be3-b918-2f0d38a97890 | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | 19 | METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | 20250123 |
| 631f7d3e-5620-4be3-b918-2f0d38a97890 | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | 19 | METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | 20250123 |
| aa151d12-bd33-4d26-848f-2195172c9700 | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | 19 | DEPO-MEDROL | 20240603 |
| aa151d12-bd33-4d26-848f-2195172c9700 | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | 19 | DEPO-MEDROL | 20240603 |
| dec92845-e713-42a3-83a7-3a48920b7eed | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | 13 | These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 1972 | 20241030 |
| dec92845-e713-42a3-83a7-3a48920b7eed | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | 13 | These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 1972 | 20241030 |
| f7d4269e-eb4c-46aa-805f-8e8662c80904 | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | 11 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | 20210414 |
| f7d4269e-eb4c-46aa-805f-8e8662c80904 | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | 11 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | 20210414 |
| de12f38c-ffa1-4d62-b9cb-238a263f6fea | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | 10 | MethylPREDNISolone Acetate Injectable Suspension, USP (40 mg/mL) and (80 mg/mL) Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | 20251231 |
| de12f38c-ffa1-4d62-b9cb-238a263f6fea | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | 10 | MethylPREDNISolone Acetate Injectable Suspension, USP (40 mg/mL) and (80 mg/mL) Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | 20251231 |
| f98314ea-a4e4-4f78-987b-3e9b45a08bb4 | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | 9 | Methylprednisolone Acetate Injectable Suspension, USP | 20220131 |
| f98314ea-a4e4-4f78-987b-3e9b45a08bb4 | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | 9 | Methylprednisolone Acetate Injectable Suspension, USP | 20220131 |
| a363f0cd-9c8e-4622-9271-171706846b96 | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | 7 | Methylprednisolone Acetate Injectable Suspension, USP | 20240301 |
| a363f0cd-9c8e-4622-9271-171706846b96 | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | 7 | Methylprednisolone Acetate Injectable Suspension, USP | 20240301 |
| 9f1b7ce6-0733-47fa-8a14-a29a4d026992 | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | 6 | Depo-Medrol ® | 20260327 |
| 9f1b7ce6-0733-47fa-8a14-a29a4d026992 | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | 6 | Depo-Medrol ® | 20260327 |
| a0cbcdb5-f657-49f7-8f86-cc5959d69db0 | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | 3 | methylPREDNISolone Acetate Injectable Suspension, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | 20260421 |
| a0cbcdb5-f657-49f7-8f86-cc5959d69db0 | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | 3 | methylPREDNISolone Acetate Injectable Suspension, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | 20260421 |
| f626db84-9cd2-4005-8182-e2150a5a925d | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | 3 | Methylprednisolone Acetate Injectable Suspension USP | 20160623 |
| f626db84-9cd2-4005-8182-e2150a5a925d | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | 3 | Methylprednisolone Acetate Injectable Suspension USP | 20160623 |
| 904b098c-9068-42ed-958f-6ab78ea42b1f | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | 1 | Methylprednisolone Acetate Injectable Suspension, USP | 20260401 |
| 904b098c-9068-42ed-958f-6ab78ea42b1f | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | 1 | Methylprednisolone Acetate Injectable Suspension, USP | 20260401 |
| f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | 1 | 20130530 | |
| f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | 1 | 20130530 | |
| 41fa78f5-8f41-415e-80f3-7fee7091df5e | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | 1 | DEPO-MEDROL ® methylprednisolone acetate injectable suspension, USP | 20110628 |
| 41fa78f5-8f41-415e-80f3-7fee7091df5e | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | 1 | DEPO-MEDROL ® methylprednisolone acetate injectable suspension, USP | 20110628 |
| faf608f3-a13d-4969-b1a6-bb0bc1de2a8e | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | 1 | MethylPREDNISolone Acetate Injectable Suspension, USP | 20110117 |
| faf608f3-a13d-4969-b1a6-bb0bc1de2a8e | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | 1 | MethylPREDNISolone Acetate Injectable Suspension, USP | 20110117 |
DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| a0cbcdb5-f657-49f7-8f86-cc5959d69db0 | methylPREDNISolone Acetate Injectable Suspension, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | Eugia US LLC | EUGIA PHARMA SPECIALITIES LIMITED | 20260421 |
| 904b098c-9068-42ed-958f-6ab78ea42b1f | Methylprednisolone Acetate Injectable Suspension, USP | Sportpharm LLC | 20260401 |
| 9a7b3837-e038-48bf-97e9-78ad463760dc | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20260121 |
| 823b0010-2b57-4e76-b5ac-4a8c2963438f | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | 20260121 |
| de12f38c-ffa1-4d62-b9cb-238a263f6fea | MethylPREDNISolone Acetate Injectable Suspension, USP (40 mg/mL) and (80 mg/mL) Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals of New York, LLC | Amneal Pharmaceuticals Private Limited | 20251231 |
| 823b0010-2b57-4e76-b5ac-4a8c2963438f | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | 20251114 |
| a0cbcdb5-f657-49f7-8f86-cc5959d69db0 | methylPREDNISolone Acetate Injectable Suspension, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | Eugia US LLC | EUGIA PHARMA SPECIALITIES LIMITED | 20251031 |
| 9a7b3837-e038-48bf-97e9-78ad463760dc | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20251006 |
| f98314ea-a4e4-4f78-987b-3e9b45a08bb4 | Methylprednisolone Acetate Injectable Suspension, USP | Sagent Pharmaceuticals | 20250302 |
| 631f7d3e-5620-4be3-b918-2f0d38a97890 | METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | Endo USA, Inc. | 20250123 |
| dec92845-e713-42a3-83a7-3a48920b7eed | These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 1972 | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 20241030 |
| a363f0cd-9c8e-4622-9271-171706846b96 | Methylprednisolone Acetate Injectable Suspension, USP | Sandoz Inc. | Lisapharma SPA | 20240301 |
| f98314ea-a4e4-4f78-987b-3e9b45a08bb4 | Methylprednisolone Acetate Injectable Suspension, USP | Sagent Pharmaceuticals | 20220131 |
| 3ce04b01-5db4-48e4-9884-1f4045e861a7 | MethylPREDNISolone A cetate Injectable Suspension, USP | REMEDYREPACK INC. | 20211228 |
| 769cc1ae-bdf4-47e4-9a9f-c6327bd7dbf4 | MethylPREDNISolone A cetate Injectable Suspension, USP | Teva Parenteral Medicines, Inc. | 20210630 |
| 978b8416-2e88-4816-8a37-bb20b9af4b1d | MethylPREDNISolone Acetate Injectable Suspension, USP | Teva Parenteral Medicines, Inc. | 20210630 |
| be407d75-c347-4adb-b165-5bd23a0a0fe5 | MethylPREDNISolone Acetate Injectable Suspension, USP | Northstar RxLLC | 20210630 |
| 754e9384-f4d4-70cf-e053-2a91aa0a9748 | Point Of Care Kit LM-DEP-2 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Bupivacaine HCI safely and effectively. See full prescribing information for Bupivacaine HCI. Bupivacaine HCI Injectables, USP Initial U.S. Approval:2013 | NuCare Pharmaceuticals,Inc. | 20210504 |
| 72dcd99f-59e3-a11f-e053-2a91aa0a4bd3 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | NuCare Pharmaceuticals,Inc. | 20210504 |
| 397cad9e-ab18-4271-8a17-9387c2358c49 | MethylPREDNISolone ACETATE Injectable Suspension USP | Proficient Rx LP | 20200201 |
| c3f1513c-b0f6-4ec7-961d-e40a741bdda7 | Methylprednisolone Acetate Injectable Suspension USP | A-S Medication Solutions | 20190828 |
| 28247e4a-0a18-0365-e054-00144ff88e88 | ReadySharp-P40 | Terrain Pharmaceuticals | 20161213 |
| f626db84-9cd2-4005-8182-e2150a5a925d | Methylprednisolone Acetate Injectable Suspension USP | Aidarex Pharmaceuticals LLC | 20160623 |
| 92cb6339-75ab-48eb-b304-19db59695883 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Proficient Rx LP | 20140205 |
| f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | Proficient Rx LP | 20130530 | |
| 468cf085-4a62-43ff-84e8-22f936406066 | National Council for Prescription Drug Programs | 20130401 | |
| 369e030c-1ea4-4104-885c-a60d6cedf072 | MethylPREDNISolone ACETATE Injectable Suspension USP | Physicians Total Care, Inc. | 20120829 |
| 82eeb304-a94b-412c-be82-081fb165c811 | National Council for Prescription Drug Programs | 20120724 | |
| 0795ee35-6cf4-4e1b-8d01-49dff46ceb91 | National Council for Prescription Drug Programs | 20120724 | |
| f2c67ef7-89c4-454b-bf7c-539fb4856011 | National Council for Prescription Drug Programs | 20120724 | |
| e8e71950-b4ff-4bb1-95c2-34961ce56314 | National Council for Prescription Drug Programs | 20120724 | |
| 36d76072-beac-4b42-ba66-9f469d4d9ef9 | National Council for Prescription Drug Programs | 20120724 | |
| dd60b1bb-4237-414e-98d9-ec80a9de0570 | National Council for Prescription Drug Programs | 20120724 | |
| d042f2d5-908d-4e80-9c5e-2e4fc590d833 | National Council for Prescription Drug Programs | 20120724 | |
| c7640deb-c893-461b-ad71-1f96ca6b6241 | National Council for Prescription Drug Programs | 20120724 | |
| 5d1907a1-afcc-42e8-b241-417e305065b0 | National Council for Prescription Drug Programs | 20120724 | |
| 6429d76a-1027-42c2-99a3-6aa41a47f3ad | National Council for Prescription Drug Programs | 20120724 | |
| aea15503-94d3-467a-9a4b-3f92251387d3 | National Council for Prescription Drug Programs | 20120724 | |
| a87c022e-a1a3-4fc7-83b5-545b9db82031 | National Council for Prescription Drug Programs | 20120724 | |
| 6dd13c01-39a1-436a-8af8-8ea5aae73547 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D10AA | Corticosteroids, combinations for treatment of acne | ATC1-4 | methylprednisolone | |
| ATC | D07AA | Corticosteroids, weak (group I) | ATC1-4 | methylprednisolone | |
| ATC | H02AB | Glucocorticoids | ATC1-4 | methylprednisolone | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | methylprednisolone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | methylprednisolone |
| MEDRT | D008775 | Methylprednisolone | CHEM | has_ingredient | methylprednisolone |
| MEDRT | D000077555 | Methylprednisolone Acetate | CHEM | has_ingredient | methylprednisolone acetate |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | methylprednisolone |
| MEDRT | D015210 | Arthritis, Gouty | DISEASE | may_prevent | methylprednisolone acetate |
| MEDRT | D015210 | Arthritis, Gouty | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_prevent | methylprednisolone acetate |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | methylprednisolone |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D001607 | Berylliosis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D001607 | Berylliosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D001932 | Brain Neoplasms | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D001932 | Brain Neoplasms | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003874 | Dermatitis Herpetiformis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D003874 | Dermatitis Herpetiformis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | methylprednisolone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methylprednisolone |
| MEDRT | D004892 | Erythema Multiforme | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D004892 | Erythema Multiforme | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_prevent | methylprednisolone acetate |
| MEDRT | D006402 | Hematologic Diseases | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006402 | Hematologic Diseases | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D006934 | Hypercalcemia | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006934 | Hypercalcemia | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D007223 | Infant | DISEASE | ci_with | methylprednisolone |
| MEDRT | D007223 | Infant | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | methylprednisolone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D007938 | Leukemia | DISEASE | may_treat | methylprednisolone |
| MEDRT | D007938 | Leukemia | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D008180 | Lupus Erythematosus, Systemic | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D008180 | Lupus Erythematosus, Systemic | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009103 | Multiple Sclerosis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D009103 | Multiple Sclerosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | methylprednisolone |
| MEDRT | D009182 | Mycosis Fungoides | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009182 | Mycosis Fungoides | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D009404 | Nephrotic Syndrome | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009404 | Nephrotic Syndrome | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D009461 | Neurologic Manifestations | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009461 | Neurologic Manifestations | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D010392 | Pemphigus | DISEASE | may_treat | methylprednisolone |
| MEDRT | D010392 | Pemphigus | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012128 | Respiratory Distress Syndrome | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012128 | Respiratory Distress Syndrome | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012507 | Sarcoidosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012507 | Sarcoidosis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012713 | Serum Sickness | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012713 | Serum Sickness | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012874 | Skin Diseases, Infectious | DISEASE | ci_with | methylprednisolone |
| MEDRT | D012874 | Skin Diseases, Infectious | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | methylprednisolone |
| MEDRT | D013585 | Synovitis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D013585 | Synovitis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D013966 | Thyroiditis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D013966 | Thyroiditis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D014397 | Tuberculosis, Pulmonary | DISEASE | may_treat | methylprednisolone |
| MEDRT | D014397 | Tuberculosis, Pulmonary | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | methylprednisolone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | methylprednisolone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | methylprednisolone acetate |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | methylprednisolone acetate |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | methylprednisolone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | methylprednisolone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | methylprednisolone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | methylprednisolone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | methylprednisolone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | methylprednisolone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000009741 | Lysosomal Function Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000009741 | Lysosomal Function Alteration | PE | has_pe | methylprednisolone acetate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 40 MG/ML (expressed as methylprednisolone acetate) |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_VET_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| ATTRIBUTES | TTY | SCD |
| ATTRIBUTES | VET_DRUG | US |
| CODES | ANDA | ANDA201835 |
| CODES | ANDA | ANDA211930 |
| CODES | ANDA | ANDA214297 |
| CODES | ANDA | ANDA214870 |
| CODES | ANDA | ANDA216502 |
| CODES | MMSL_CODE | CD2312 |
| CODES | MMSL_CODE | MTH_RXN_BD2312 |
| CODES | RxCUI | 1358610 |
| CODES | SNOMEDCT | 781994004 |
| CODES | SPL_SET_ID | 631f7d3e-5620-4be3-b918-2f0d38a97890 |
| CODES | SPL_SET_ID | 904b098c-9068-42ed-958f-6ab78ea42b1f |
| CODES | SPL_SET_ID | a0cbcdb5-f657-49f7-8f86-cc5959d69db0 |
| CODES | SPL_SET_ID | a363f0cd-9c8e-4622-9271-171706846b96 |
| CODES | SPL_SET_ID | de12f38c-ffa1-4d62-b9cb-238a263f6fea |
| CODES | SPL_SET_ID | dec92845-e713-42a3-83a7-3a48920b7eed |
| CODES | SPL_SET_ID | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 |
| CODES | SPL_SET_ID | f98314ea-a4e4-4f78-987b-3e9b45a08bb4 |
| CODES | VUID | 4003432 |
| NAMES | Prescribable Synonym | methylPREDNISolone acetate 40 MG/ML Injectable Suspension |
| NAMES | RXNAV_STR | methylPREDNISolone acetate 40 MG/ML Injectable Suspension |
| NAMES | RxNorm Name | methylprednisolone acetate 40 MG/ML Injectable Suspension |
| NAMES | Tallman Synonym | methylPREDNISolone acetate 40 MG/ML Injectable Suspension |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |